VENU VENU
Company Profile ↓Company Overview
VENU (VENU) is a publicly traded company listed on with a market capitalization of $93.24M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 27.4% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $17.90M (+0.4% YoY); net profit $-44.09M.
- Trailing 12 Months Year-on-year growth — revenue +0.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 27.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 27.39% |
| 1 Year: | 0.35% |
Stock Price Performance
| 1 Year: | -83.96% |
| 6 Months: | -61.36% |
| 3 Months: | -44.76% |
| 1 Month: | -7.30% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)40.84 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 27.4% over 5 years.
CONS
- Trading 88.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.91M | 3.94M | 4.18M | 5.45M | - | 3.50M | 4.49M | 5.38M | 4.53M | 3.90M |
| Cost of Revenue | - | - | - | - | - | 2.59M | 3.07M | 3.03M | 3.77M | 3.36M |
| Gross Profit | - | - | - | - | - | 913.93K | 1.42M | 2.36M | 760.43K | 538.74K |
| Operating Expenses | - | - | - | - | - | 19.46M | 11.72M | 12.33M | 14.97M | 12.02M |
| Operating Income | -2.75M | -12.97M | -4.35M | -3.68M | - | -18.54M | -10.31M | -9.97M | -14.21M | -11.49M |
| EBITDA | - | - | - | - | - | -17.13M | -8.92M | -8.64M | -5.64M | -9.09M |
| Interest Expense | - | - | - | - | 1.19M | 922.89K | 2.01M | - | 2.01M | 2.98M |
| Pretax Income | - | - | - | - | - | -19.43M | -12.30M | -9.29M | -9.75M | -14.44M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - |
| Net Income | -2.77M | -15.60M | - | -3.93M | - | -18.06M | -11.42M | -6.36M | -8.25M | -13.76M |
| Diluted EPS | - | - | - | -0.13 | - | -0.48 | -0.30 | -0.15 | - | -0.29 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 8.66M | 12.60M | 17.83M | 17.90M |
| Cost of Revenue | 5.36M | 7.77M | 10.71M | 12.45M |
| Gross Profit | 3.30M | 4.83M | 7.13M | 5.45M |
| Operating Expenses | 7.85M | 15.96M | 34.50M | 58.48M |
| Operating Income | -4.55M | -11.13M | -27.38M | -53.03M |
| EBITDA | -6.44M | -9.18M | -26.09M | -40.02M |
| Interest Expense | 397.12K | 331.67K | 3.20M | 4.58M |
| Pretax Income | -8.02M | -11.39M | -32.95M | -50.78M |
| Tax Provision | - | - | - | - |
| Net Income | -6.92M | -10.52M | -30.34M | -44.09M |
| Diluted EPS | -0.18 | -0.28 | -0.86 | -1.10 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 52.90M | 83.22M | 178.42M | 370.56M |
| Current Assets | 23.86M | 20.60M | 39.05M | 44.33M |
| Cash & Equivalents | 23.47M | 20.20M | 37.97M | 41.31M |
| Inventory | 87.16K | 185.75K | 225.28K | 474.47K |
| Receivables | - | - | - | - |
| Total Liabilities | 14.14M | 21.24M | 47.60M | 171.70M |
| Current Liabilities | 3.49M | 4.92M | 24.53M | 57.35M |
| Long Term Debt | 6.99M | 11.18M | 14.10M | 88.51M |
| Total Debt | 11.42M | 15.38M | 27.02M | 107.43M |
| Total Equity | 15.97M | 30.75M | 95.72M | 132.87M |
| Shares Outstanding | 37.16M | 37.16M | 37.85M | 43.17M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -700.75K | -4.88M | 3.76M | 7.65M |
| Investing Cash Flow | -4.43M | -31.17M | -72.41M | -133.43M |
| Financing Cash Flow | 24.40M | 32.77M | 86.42M | 129.12M |
| Capital Expenditure | -8.12M | -31.17M | -72.48M | -141.66M |
| Free Cash Flow | -8.82M | -36.04M | -68.73M | -134.01M |
| Net Change in Cash | 19.28M | -3.27M | 17.77M | 3.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 38.1% | 38.3% | 40.0% | 30.4% |
| Operating Margin % | -52.6% | -88.4% | -153.5% | -296.3% |
| Net Margin % | -80.0% | -83.5% | -170.1% | -246.4% |
| ROE % | -43.4% | -34.2% | -31.7% | -33.2% |
| ROCE % | -9.2% | -14.2% | -17.8% | -16.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VENU
VENU's Two Amphitheaters Take Shape in Oklahoma and Texas - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZ0lkOWJ5TnZEa3R2ZFdEa1IwSnBuQXU5M3pBZjU4N0VuWVVWTTVDcURsUDV6cGJmQWJMcW50NGNtanJYb3pZZW1SN0ptUzFVbDM1QmthTU9BRGo4cDhYTW11TjE3ZWhUTFcyd3pCd2tLUzdjZTBLQXpzWVlnV2poYmRkYlE1ZDVNR0Z5VG…
Venu raises $25M in debt for its Oklahoma venue, months after CEO said: ‘We are done.’ - Music Business Worldwide
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE5aWmZHYW52eUFzXzVfajBxVkxXdXc5akNmMXQyd202MEVMek8yaTE2T3BvNXItaG40R0NmSnFPQVl0cUotVW84MWhRNlVUaUR1VEg2UDR3aUdBaHE5RGZTSVBVMmJNS1BsdlJZZzdwMGw?oc=5" target="_blank">Venu raises $25M…
VENU Shares Rise After $25 Million Financing for Oklahoma Amphitheater - Moomoo
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQSUhjaHJXdmMwWV93MFlZeDZuRGNBejB1dDBiaU1BanBIWVJRWEkwejUzQmY4MGhNWF9nV2RhVktqSWFtSy1ra09CbDVMUUo4WlFPVzBUSUpnLXVtRVdndGpmXy1yTVBHYzdhZC16YlRySHN5bF9DeHpVdUJLQjVocEVDUmY2UU8yeUxCZD…
$VENU stock is down 13% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPblhyWGg2NEEwbEdpOFJNUnFwcWoxMHRQOUtUcHBMWlFQQ2hGNU9ETTV0N2ExaW5aSDdzdkphMkItaklaRHoxWGhRaHpMOEFFd0lCUU92aERkV1lyeVl6OXFuZm0xOV81UHNQalkzTjkzWGpLZjJxY2I2VzdlbzZZeVBRcmJkdG1mVGdLOE…
Veteran Investor and Widely Followed Market Analyst Shah Gilani Calls VENU Stock "Significantly Undervalued" - Nasdaq
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQVVHSmk4dm9ZNVVaMThOcVFMRy11Wi1kRVR3aXVTMWRKTl9TVnBHbWVoM0Y1cjJsOFhfQndXbXJualFBRkNlc0tMYUxkc0VQT3AyeEF2SE11WHotdGgwekpNcWIycjhEZjVVelZONEVRdDhSSGJ3MWVIUkZ6d0lmRWlJT3JnSGRCZkt1Zj…
Venu will release fiscal Q2 results before its Aug. 13 call - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxObmlYZ3dSYXRXSkpsNHZic3prYVNEaVdRUk13a3RBNlppVXdFWkZaTVdMWmtpZUFCUW14WE5zeWdYNkJqcy1pdTJUdFhjVDIzX3ZDNUdHekJ6LVh4VDNnVUROSE84eHdxU1hYdW5TV0RuV2VGRElTWGM3dkdTRm5oOU43MGt3clF3NE53Q1…
VENU — Frequently Asked Questions
What is the current share price of VENU?
As of 2026-08-05 17:25 PDT, VENU trades at $2.16 on NASDAQ/NYSE. Its 52-week range is $2.03 to $18.10.
What is the market capitalisation of VENU?
VENU has a market capitalisation of $93.24M on NASDAQ/NYSE.
What is the P/E ratio of VENU?
VENU trades at a trailing price-to-earnings (P/E) ratio of -1.96. Its price-to-book (P/B) ratio is 0.70.
What is the return on equity (ROE) of VENU?
VENU has a return on equity (ROE) of -33.19%. Its return on capital employed (ROCE) is -16.93%.
Is VENU a good stock to buy?
This page provides a data-driven analysis of VENU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.